Home
Conditions
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Clinical trial condition

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Explore clinical trials studying Precursor T-Cell Lymphoblastic Leukemia-Lymphoma. Study availability and eligibility vary by location and protocol.

294 public trials 62 recruiting studies

Refine in advanced search Browse all conditions

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma trial results

Completed

Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy

NCT00066599

Conditions: Agranulocytosis, Blast Crisis, Blood Protein Disorders, +89 more
Locations: Children's Hospital of Orange County Orange, California, United States

Children's Hospital and Health Center, San Diego San Diego, California, United States

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States

Duke Comprehensive Cancer Center Durham, North Carolina, United States

View Trial Details

Completed

ZD0473 and Doxorubicin in Treating Patients With Advanced Solid Tumors or Lymphoma

NCT00016172

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +43 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Pyroxamide in Treating Patients With Advanced Cancer

NCT00042900

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +90 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma

NCT00659568

Conditions: Adenocarcinoma, Blood Protein Disorders, Breast Cancer, +84 more
Locations: London Regional Cancer Program at London Health Sciences Centre London, Ontario, Canada

View Trial Details

Completed

Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer

NCT00045006

Conditions: Adenocarcinoma, Adnexal Diseases, Blood Protein Disorders, +110 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

BCX-1777 in Treating Patients With Refractory Cancer

NCT00073944

Conditions: Adenocarcinoma, Adenocarcinoma Of Esophagus, Adnexal Diseases, +140 more
Locations: Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Monoclonal Antibody Therapy in Treating Patients With Advanced or Recurrent Lymphoma

NCT00006009

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +19 more
Locations: Stanford University Medical Center Stanford, California, United States

View Trial Details

Completed

PXD101 and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas

NCT00348985

Conditions: Adult Grade III Lymphomatoid Granulomatosis, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +109 more
Locations: University of Colorado Denver, Colorado, United States

View Trial Details

Completed

Combination Chemotherapy in Treating Patients With Advanced Cancer

NCT00003956

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +36 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease

NCT00521430

Conditions: Anemia, Anemia, Aplastic, Anemia, Refractory, +76 more
Locations: Asan Medical Center - University of Ulsan College of Medicine Seoul, South Korea

View Trial Details

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma trial results

Related conditions